Arsenic sulfide induces miR-4665-3p to inhibit gastric cancer cell invasion and migration
Arsenic sulfide induces miR-4665-3p to inhibit gastric cancer cell invasion and migration
复制标题
硫化砷诱导miR-4665-3p抑制胃癌细胞侵袭和迁移
DOI:
10.2147/dddt.s209219
复制
发表时间:
2019-08
期刊:
影响因子:
--
通讯作者:
Chen Siyu
中科院分区:
文献类型:
--
作者:
Zhang Xiuli;Tan Zhen;Kang Ting;Zhu Chuanying;Chen Siyu
Purpose Gastric carcinogenesis is a multistep process and is the second-highest cause of cancer death worldwide with a high incidence of invasion and metastasis. MicroRNAs (miRNAs) engage in complex interactions with the machinery that controls the transcriptome and concurrently target multiple mRNAs. Recent evidence has shown that miRNAs are involved in the cancer progression, including promoting cell-cycle, conferring resistance to apoptosis, and enhancing invasiveness and metastasis. Here, we aim to elucidate the roles of miRNAs, especially microRNA-4665-3p (miR-4665-3p), in the inhibitory effect of arsenic sulfide in gastric cancer (GC). Methods The arsenic sulfide-induced miRNA expression alterations in AGS cells was determined by miRNA microarray. RT-PCR was used to further verify the arsenic sulfide-regulated miRNAs in GC tissues. The inhibition of miR-4665-3p on the migration and invasion of GC cells were determined by wound healing assay and transwell assay. Western blot analysis was used to detect the expression of EMT related proteins and the putative target of miR-4665-3p. Results The miR-4665-3p was up-regulated by arsenic sulfide and showed inhibition upon the migration and invasion of GC cells. MiRBase and Western blotting indicated that miR-4665-3p directly down-regulated the oncoprotein GSE1. Morphological observation also indicated that the up-regulation of miR-4665-3p inhibits the EMT in GC cells. Conclusion Our data demonstrates that the increased expression of miR-4665-3p induced by arsenic sulfide suppresses the cell invasion, metastasis and EMT of GC cells, and has the potential to be a novel therapeutic target in GC.
登录
查看更多内容
DOI:
10.1891/9780826121646.0002
发表时间:
2018-09
期刊:
Cancer Rehabilitation
影响因子:
--
作者:
K. Miller;R. Siegel;R. Khan;A. Jemal
通讯作者:
K. Miller;R. Siegel;R. Khan;A. Jemal
影响因子:
3
作者:
Lee SH;Lee SJ;Jin SM;Lee NH;Kim DH;Chae SW;Sohn JH;Kim WS
通讯作者:
Kim WS
影响因子:
11.5
作者:
Yu, XM;Lo, CY;Luk, JM
通讯作者:
Luk, JM
DOI:
10.1016/j.bbrc.2016.01.168
发表时间:
2016-02-26
影响因子:
3.1
作者:
Chai, Peng;Tian, Jingzhong;Liu, Bin
通讯作者:
Liu, Bin
DOI:
10.2147/dddt.s74379
发表时间:
2015
期刊:
Drug design, development and therapy
影响因子:
--
作者:
Zhang L;Tian W;Kim S;Ding W;Tong Y;Chen S
通讯作者:
Chen S